Clinical and gene mutation characteristics of patients with hereditary ellipsocytosis: nine cases report and literature review / 中华血液学杂志
Chinese Journal of Hematology
; (12): 316-320, 2023.
Article
em Zh
| WPRIM
| ID: wpr-984621
Biblioteca responsável:
WPRO
ABSTRACT
Objective:
To report gene mutations in nine patients with hereditary elliptocytosis (HE) and analyze the characteristics of pathogenic gene mutations in HE.Methods:
The clinical and gene mutations of nine patients clinically diagnosed with HE at Institute of Hematology & Blood Diseases Hospital from June 2018 to February 2022 were reported and verified by next-generation sequencing to analyze the relationship between gene mutations and clinical phenotypes.Results:
Erythrocyte membrane protein gene mutations were detected among nine patients with HE, including six with SPTA1 mutation, one with SPTB mutation, one with EPB41 mutation, and one with chromosome 20 copy deletion. A total of 11 gene mutation sites were involved, including 6 known mutations and 5 novel mutations. The five novel mutations included SPTA1 c.1247A>C (p. K416T) in exon 9, c.1891delG (p. A631fs*17) in exon 15, E6-E12 Del; SPTB c.154C>T (p. R52W) ; and EPB41 c.1636A>G (p. I546V) . Three of the six patients with the SPTA1 mutation were SPTA1 exon 9 mutation.Conclusion:
SPTA1 is the most common mutant gene in patients with HE.Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Esferocitose Hereditária
/
Éxons
/
Eliptocitose Hereditária
/
Membrana Eritrocítica
/
Sequenciamento de Nucleotídeos em Larga Escala
/
Mutação
Limite:
Humans
Idioma:
Zh
Revista:
Chinese Journal of Hematology
Ano de publicação:
2023
Tipo de documento:
Article